+++ Program With Confirmed Speakers: Titles and Speakers are Subject to Change Without Notice +++

MAY 11, 2021 (GERMAN TIME / UTC+2) 

09:30
Gateway on cbes.berlin opens


10.00 - 10.30 Welcome Remarks by our Co-Hosts
Heyo Kroemer
Chief Executive Officer
Charité Universitätsmedizin - Berlin, Germany

Christopher Baum
Chairman of the Board of Directors of Berlin Institute of Health and
Chief Translational Research Officer of Charité – Universitätsmedizin Berlin, Germany


10.30 - 11.00 Special Keynotes Translational Innovation in Scotland
TBA
Jason Leitch CBE
National Clinical Director
Scottish Government

Precision Medicine: The Living Laboratory
Dame Anna Dominiczak
Institute of Cardiovascular & Medical Sciences
University of Glasgow, Scotland


11.00 - 12.00 Emerging Technologies for Point of Care Solutions
DIGITAL PANEL
Point of care technologies have gained a special role in the last year. The fields of application are diverse and will significantly change the way we deal with common diseases. The panel will present the many possibilities and also address the specifics from development to application.

Moderation: Madeleine Künz
Kalms Consulting, Germany

Oliver Hayden
Heinz-Nixdorf-Chair of Biomedical Electronics, Director TranslaTUM
TU München, Germany

Nicholas L. Mills
BHF Butler Senior Clinical Research Fellow 
BHF Centre for Cardiovascular Sciences & Usher Institute 
The University of Edinburgh, Scotland

Sarah Levy Schreier
Chief Technology Officer
Sight Diagnostics, Israel


12.00 - 13.20 Networking Break


13.20 - 13.30 Seeking Excellence in Academic, Clinical  and Commercial Science
DIGITAL KEYNOTE
Richard A. Young
Professor of Biology
Massachusetts Institute of Technology, MA;
Member, Whitehead Institute


13.30 - 14.30 Next Generation Immune Engineering
DIGITAL PANEL
The expert session aims at highlighting the potential of novel immunotherapy technologies. Experts from academia and industry will explain the challenges along the long path from discovery to breakthrough.

Moderation: Nina Rawal
Founder
Emerging Health Ventures, Sweden

Katalin Karikó
Senior Vice President
Biontech Group, Germany

Sekar Kathiresan
Founder and Chief Executive Officer
Verve Therapeutics, MA

Yoram Palti
Professor Emeritus Physiology and Biophysics
Technion University, Israel;
Founder and Chief Technology Officer
Novocure, Israel


14.30 - 15.00 Networking Break


15.00 - 15.30 TBA
INTERVIEW AND LIVE Q&A
Arthur Caplan
Mitty Professor of Bioethics
Grossman School of Medicine
New York University, NY

interviewed by: 
Mildred Z. Solomon
President ot The Hastings Center;
Professor for Global Health and Social Medicine
Harvard Medical School, Cambridge, MA


15.30 - 16.30 Tissue Engineering - A Loophole to Fight the Longterm Effects of CoViD-19?
DIGITAL PANEL
Treatments based on tissue engineering offer promising perspectives in complex therapeutic courses related to the long-term effects of Covid-19. This session will present the diverse and complex applications and venture an outlook on the future of this field of research.

Anh Hoang-Lindsay
Chief Scientific Officer
Sofregen Medical, Boston, MA

Yaakov Nahmias
Director, Grass Center for Bioengineering 
The Hebrew University of Jerusalem, Israel;
Founder
Tissue Dynamics, Israel


16.30 - 17.30 Networking Break


17.30 - 18.00 Post-CoViD Investment Strategies
DIGITAL KEYNOTE


18.00 - 18.40 Post-CoViD Investment Strategies
DIGITAL PANEL
The panel will highlight the challenges for investors and entrepreneurs that have to be faced in the last year and provide an outlook for both sides to adapt to future conditions.

Moderation: Gaylene Anderson
US Director, Contracts and Alliance Management 
Boehringer Ingelheim Pharmaceuticals, CT 

Meridith Fisher
Partner
Mass General Brigham Ventures, Cambridge, MA

Gur Roshwalb
Managing Partner
aMoon, Israel

Jackie Waring
Founder and Business Angel
Investing Women Scotland, Edinburgh


18.40 - 19.00 A Better Public Health Surveillance Strategy Needs New Technologies?
DIGITAL FIRESIDE CHAT
John Brownstein
Chief Information Officer 
Harvard Medical School, Cambridge, MA

interviewed by: 
Marc Filerman
Managing Director
German Accelerator Life Sciences, Boston, MA, USA

MAY 11, 2021 WORKSHOPS
A variety of inspiring workshops will be provided. Full overview can be found here.

MAY 11, 2021 LIFESCIENCES VENTUREMARKET

We cordially invite start-ups to present their idea and business model in pre-recorded pitches. More information can be found here.

+++ Preliminary Program: Titles and Speakers are Subject to Change Without Notice +++